News
CHENGDU, China and ROCKAWAY, NJ, USA I May 02, 2025 I Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech Ltd. (“Vanotech”) announced today the first patient dosed in the VAN-2401 ...
Phase 4 saw TV shows folded into the MCU's interconnected storylines more than ever before and this has continued throughout Phase 5 and the already-confirmed Phase 6, which will wrap up with an ...
Department of Space, Earth, and Environment, Division of Energy Technology, Chalmers University of Technology, Chalmersplatsen 4, Gothenburg, SE-41296, Sweden ...
UConn announced Thursday that it raised about $720 million from lead donors during the “quiet phase” of the campaign, which began in 2020. The $1.5 billion fundraising effort is the largest in ...
KIITEE Phase 1 Results 2025 has been declared at kiitee.kiit.ac.in. The direct link to check is given below. The Kalinga Institute of Industrial Technology, KIIT, has declared the KIITEE 2025 ...
Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum tolerated dose in up to 50 patients. The FDA granted clearance to the ...
The Kalinga Institute of Industrial Technology has released the KIITEE 2025 Phase 1 results for its entrance exam. Candidates can now check their scores, subject-wise marks, and overall rank ...
The Kalinga Institute of Industrial Technology (KIIT) has announced the KIITEE 2025 result for Phase 1. Candidates who appeared for the exam can now check their results online at the official ...
HHS and FDA are planning to phase out eight synthetic food dyes. During a press conference on Tuesday, Health and Human Services Secretary Robert F. Kennedy Jr. unveiled a plan to start phasing ...
Ascletis Pharma’s obesity pill was less effective at its high dose than at lower doses in an early-stage trial, the biotech ...
Rabat – Morocco is stepping up efforts to strengthen and diversify its gas resources as the country aims to develop the first phase of a liquefied natural gas terminal near the eastern city of ...
In bronchiectasis, neutrophilic inflammation is associated with an increased risk of exacerbations and disease progression. Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results